Comparison of Standard of Care Guidelines for Mycoplasma Genitalium Infections Among Men With Non-gonococcal Urethritis

Stopped early

Conditions studied: Mycoplasma Genitalium Infection

In brief

The purpose of this protocol is to determine the difference in clearance of Mycoplasma genitalium (MG) when using the Australian management protocol versus the current Centers of Disease Control (CDC) treatment guidelines for US standard of care (SOC), to determine the proportion of men from the Deep South, with NGU attributable to MG, and to determine the proportion of MG cases that harbor the macrolide-resistance associated with mutation.

Key facts

Study ID

NCT03910907

Run by

University of Alabama at Birmingham

People needed

10

Starts

2019-11-19

Expected to finish

2020-03-20

Last updated by the study team

2023-06-02

Who can join

Age: 18 and older, up to 99. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Presenting with symptoms of urethritis (dysuria and/or urethral discharge)

You may not qualify if…

• Non-English speaking

Where it is running

• UAB — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.